2020 American Transplant Congress » Poster Session C: All Infections (Excluding Kidney & Viral Hepatitis)

3:30pm-4:00pm

Absolute Lymphocyte Count: Is There a “Safety Corridor?”

G. Elhelou¹, B. Lahr², R. Razonable³

3:30pm-4:00pm

Artificial Intelligence May Predicts Early Sepsis in Liver Transplantation

R. D. Kamaleswaran¹, R. Lowell Davis², J. D. Eason³, S. Sataphaty⁴, V. R. Mas⁵, D. Maluf³

3:30pm-4:00pm

Brincidofovir for Treatment of Disseminated Human Adenovirus Infection in Pediatric Solid Organ Transplant Recipients

J. Londeree¹, R. Garro¹, R. Romero², R. George¹, P. Winterberg¹, R. Liverman³, A. Serluco³, S. Shin¹, I. Yildirim⁴

3:30pm-4:00pm

Epidemiology of Cytomegalovirus (CMV) in Pediatric Solid Organ Transplant Recipients (SOTR) at Texas Children’s Hospital (TCH)

K. Valencia, K. Hosek, E. Moulton, F. Munoz, G. Demmler-Harrison, C. Bocchini

3:30pm-4:00pm

Evaluation Of Typical Renal Transplant Infections In Simultaneous Heart-kidney Transplant Recipients

E. J. Henricksen¹, U. Wang¹, R. Lee¹, R. Imai¹, A. Puing², A. Couture², A. Multani³, Y. Moayedi⁴, C. Lenihan⁵, K. K. Khush⁶, J. J. Teuteberg⁵

3:30pm-4:00pm

Evaluation of Oral Candidiasis Incidence at Large Academic Medical Center in Absence of Pharmacologic Prophylaxis at Discharge

C. Sammons¹, M. Norris², N. Casciello²

3:30pm-4:00pm

Evaluation of an Intervention to Reduce Underdosing of Valganciclovir for Primary Prophylaxis of Cytomegalovirus Infection in Donor Seropositive/Recipient Seronegative Kidney and Liver Transplant Recipients

L. Al Bizri¹, Z. S. Chaudhry², A. Vahia², J. Williams², J. C. Lemos-Ramirez³, B. Summers⁴, A. Patel⁵, S. Nagai⁶, O. Abreu Lanfranco², M. Ramesh², R. Del Busto², G. Alangaden²

3:30pm-4:00pm

Letermovir for CMV Prophylaxis and Treatment of Resistant/ Refractory CMV Disease in Solid Organ Transplant Recipients

M. Miller¹, S. Scherger², E. Benamu², V. Bajrovic², P. Ramanan², N. Madinger², M. Barron², S. Johnson², T. Campbell², A. Gray³, A. Weinberg⁴, M. Abidi²

3:30pm-4:00pm

Next-Generation Sequencing to Assess Cytomegalovirus Viral Populations During the Course of CMV Infection

G. Elhelou¹, R. Razonable²

3:30pm-4:00pm

Phage Therapy for Mycobacterium Abscessus (Mab) Infection after Lung Transplant (LT)

W. Garner¹, R. Dedrick², C. Guerrero², M. Morrell¹, J. D'Cunha³, P. Sanchez¹, G. Hatfull², G. Haidar¹

3:30pm-4:00pm

Pharmacokinetics of Maribavir in Subjects with Moderate Hepatic Impairment

I. H. Song¹, K. Ilic², J. Wu³

3:30pm-4:00pm

Pneumocystis Pneumonia Occurrence and Prophylaxis Duration in Kidney Transplant Recipients According to Perioperative Treatment with Rituximab

Y. Ko, Y. Kim, D. Han, H. Kwon

3:30pm-4:00pm

Proinflammatory Cytokines Including IL-18 Correlate with Cytomegalovirus DNAemia in Solid Organ Transplant Recipients

A. H. Karaba, A. Figueroa, S. C. Ray, R. K. Avery, A. L. Cox

3:30pm-4:00pm

Risk Factors of Invasive Fungal Infections in Liver Transplantation: Systematic Review and Meta-Analysis

P. Phoompoung¹, S. Herrera², A. Perez Cortes Villalobos¹, F. Foroutan¹, A. Orchanian-Cheff¹, S. Husain¹

3:30pm-4:00pm

Statin Use May Be Associated with Lower Risk of Invasive Aspergillosis in Lung Transplant Recipients

A. Perez Cortes Villalobos, F. Foroutan, S. Davoudi, T. Martinu, J. Tikkanen, L. Singer, S. Keshavjee, S. Husain